• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

甲泼尼龙冲击疗法的不良反应：急性呼吸窘迫综合征。

Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome.

作者信息

Ashtari Fereshteh, Soltani Rasool, Shokouhi Shervin, Rismanbaf Ali, Hajiahmadi Somayeh, Hakamifard Atousa

机构信息

Isfahan Neuroscience Research Center Isfahan University of Medical Sciences Isfahan Iran.

Department of Clinical Pharmacy and Pharmacy Practice School of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences Isfahan Iran.

出版信息

Clin Case Rep. 2021 Jul 16;9(7):e04468. doi: 10.1002/ccr3.4468. eCollection 2021 Jul.

DOI:10.1002/ccr3.4468
PMID:34295489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283859/
Abstract

Methylprednisolone pulse therapy has significant anti-inflammatory effects in multiple sclerosis. Acute respiratory distress syndrome as a probable adverse effect of methylprednisolone pulse therapy in MS patients should be considered.

摘要

甲基强的松龙冲击疗法在多发性硬化症中具有显著的抗炎作用。应考虑急性呼吸窘迫综合征作为甲基强的松龙冲击疗法在MS患者中可能产生的不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/7ca0439d6fb0/CCR3-9-e04468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/c9f7de2c61ea/CCR3-9-e04468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/e47dc12d0d05/CCR3-9-e04468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/f6481103e398/CCR3-9-e04468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/7ca0439d6fb0/CCR3-9-e04468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/c9f7de2c61ea/CCR3-9-e04468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/e47dc12d0d05/CCR3-9-e04468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/f6481103e398/CCR3-9-e04468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5e/8283859/7ca0439d6fb0/CCR3-9-e04468-g005.jpg

相似文献

1
Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome.甲泼尼龙冲击疗法的不良反应：急性呼吸窘迫综合征。
Clin Case Rep. 2021 Jul 16;9(7):e04468. doi: 10.1002/ccr3.4468. eCollection 2021 Jul.
2
Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies.不同剂量甲泼尼龙治疗急性呼吸窘迫综合征的效果：来自动物和临床研究的结果。
BMC Pulm Med. 2022 Sep 16;22(1):348. doi: 10.1186/s12890-022-02148-y.
3
Efficacy and safety of methylprednisolone against acute respiratory distress syndrome: A systematic review and meta-analysis.甲泼尼龙治疗急性呼吸窘迫综合征的疗效和安全性：系统评价和荟萃分析。
Medicine (Baltimore). 2021 Apr 9;100(14):e25408. doi: 10.1097/MD.0000000000025408.
4
Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.延长甲泼尼龙治疗对未缓解的急性呼吸窘迫综合征的影响：一项随机对照试验。
JAMA. 1998 Jul 8;280(2):159-65. doi: 10.1001/jama.280.2.159.
5
Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.急性呼吸窘迫综合征期间及对甲基强的松龙治疗反应时的I型和III型前胶原氨基端前肽水平
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1432-41. doi: 10.1164/ajrccm.158.5.9801107.
6
Prolonged Methylprednisolone Therapy in the Fibro-Proliferative Phase of Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征纤维增殖期的长期甲基强的松龙治疗
Cureus. 2021 Nov 25;13(11):e19906. doi: 10.7759/cureus.19906. eCollection 2021 Nov.
7
Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.甲泼尼龙输注治疗小儿急性呼吸窘迫综合征的双盲、安慰剂对照试验性随机试验
Pediatr Crit Care Med. 2015 Mar;16(3):e74-81. doi: 10.1097/PCC.0000000000000349.
8
Acute respiratory distress syndrome associated with rapid aggravation of rheumatoid arthritis.急性呼吸窘迫综合征伴类风湿关节炎迅速加重。
Mod Rheumatol. 2010 Feb;20(1):77-80. doi: 10.1007/s10165-009-0228-3. Epub 2009 Sep 26.
9
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.皮质类固醇对持续性急性呼吸窘迫综合征的疗效与安全性
N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693.
10
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.脉冲类固醇疗法在多发性硬化症复发中的短期安全性。
Clin Neuropharmacol. 2013 Jan-Feb;36(1):1-3. doi: 10.1097/WNF.0b013e3182764f91.

引用本文的文献

1
Steroid-Responsive Progressive Subacute Cerebellar Ataxia: An Unrecognized Subtype of Immune-Mediated Ataxia.类固醇反应性进行性亚急性小脑共济失调：一种未被认识的免疫介导性共济失调亚型。
Cerebellum. 2025 Apr 5;24(3):80. doi: 10.1007/s12311-025-01829-8.

本文引用的文献

1
Pharmacological agents for adults with acute respiratory distress syndrome.用于成人急性呼吸窘迫综合征的药物制剂。
Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD004477. doi: 10.1002/14651858.CD004477.pub3.
2
Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?对多发性硬化症中皮质类固醇的机制性见解：战马还是变色龙？
Clin Neurol Neurosurg. 2014 Apr;119:6-16. doi: 10.1016/j.clineuro.2013.12.021. Epub 2014 Jan 10.
3
Drug-associated acute lung injury: a population-based cohort study.药物相关性急性肺损伤：基于人群的队列研究。
Chest. 2012 Oct;142(4):845-850. doi: 10.1378/chest.11-2103.
4
Diagnosis and management of cardiogenic pulmonary edema.心源性肺水肿的诊断与管理
Acta Med Indones. 2010 Jul;42(3):176-84.
5
Diffuse alveolar damage and recurrent respiratory failure secondary to sertraline.舍曲林导致的弥漫性肺泡损伤和反复呼吸衰竭。
Am J Ther. 2012 Jul;19(4):e132-5. doi: 10.1097/MJT.0b013e3181ed8363.
6
The acute respiratory distress syndrome.急性呼吸窘迫综合征
Ann Intern Med. 2004 Sep 21;141(6):460-70. doi: 10.7326/0003-4819-141-6-200409210-00012.
7
Drug-induced lung disease: high-resolution CT and histological findings.药物性肺疾病：高分辨率CT及组织学表现
Clin Radiol. 2002 Apr;57(4):292-9. doi: 10.1053/crad.2001.0792.
8
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.